Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co‐morbidity-Reference-Cited by-同舟云学术

Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co‐morbidity

Published:2018-12-10 Issue: Volume: Page:
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Kumar Nathella P.¹^ORCID,Moideen Kadar¹,Bhootra Yukthi¹,Nancy Arul¹²,Viswanathan Vijay²,Shruthi Basavaradhya S.²,Sivakumar Shanmugam³,Natarajan Mohan³,Kornfeld Hardy⁴,Babu Subash¹⁵

Affiliation:

1. National Institutes of Health—NIRT—International Center for Excellence in Research Chennai India

2. Prof. M. Viswanathan Diabetes Research Center Chennai India

3. National Institute for Research in Tuberculosis Chennai India

4. University of Massachusetts Medical School Worcester MA USA

5. LPD, NIAID NIH Bethesda MD USA

Funder

Indian Council of Medical Research

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Office of AIDS Research

CRDF Global

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13023

Reference50 articles.

1. Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies

2. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases

3. Bi-directional screening for tuberculosis and diabetes: a systematic review

4. Diabetes and the risk of tuberculosis: a neglected threat to public health?

5. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds;Frontiers in Microbiology;2024-06-20

2. Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective;Exploration;2024-03-05

3. Evaluation of Systemic Inflammation Before and After Standard Anti-tuberculosis Treatment in Patients With Active Pulmonary Tuberculosis and Diabetes Mellitus;Cureus;2024-03-02

4. Computed tomography findings in patients with pulmonary tuberculosis and diabetes at an infectious disease hospital in China: a retrospective cross-sectional study;BMC Infectious Diseases;2023-06-27

5. Association Between Soluble Cluster of Differentiation 14 Levels and Active Tuberculosis Infection in Human Immunodeficiency Virus Patients;Open Access Macedonian Journal of Medical Sciences;2023-06-04